Rice CS
Events
ALL EVENTS
Moshe Vardi to host Kate Crawford's Technology, Culture, and Society Lecture Thu, 01/27/2022 - 11:35
Crawford, professor and leading researcher in the social impacts of AI, will present “Atlas of AI: Mapping the Political Economies of Planetary Computation”
Moshe Vardi to give Vienna Logic Day Lecture on the adverse consequences of technology Mon, 01/10/2022 - 13:25
In celebration of UNESCO's World Logic Day, Vardi will present “From Greek Paradoxes to Political Paradoxes"
Alumni Leo Elworth (PhD '19): Award Winning Posters and Pitches Thu, 01/06/2022 - 14:52
Elworth honed his presentation skills with the help of Rice's ACTIVATE Engineering Communication program
Rice CS PhD students win Ken Kennedy Institute graduate fellowships Wed, 01/05/2022 - 11:16
Zhiwei Zhang awarded Andrew Ladd Fellowship and ZhaoZhuo Xu wins BP Fellowship
Treangen, Stadler confirm presence of omicron in Houston wastewater treatment plants Mon, 12/13/2021 - 11:35
In collaboration with the Houston Health Department, Rice researchers found the SARS-CoV-2 variant in eight of the city’s 39 facilities
Omicron mutations may help SARS-CoV-2 evade antibodies Thu, 12/02/2021 - 12:58
Treangen Lab software reveals spike mutations that could help virus variant defeat vaccinations
Reginald DesRoches, former dean of engineering, named 8th president of Rice University Thu, 11/11/2021 - 16:10
Distinguished civil engineer to replace David Leebron, president of Rice since 2004, effective July 1, 2022
The Ken Kennedy Institute awards Computational Science & Engineering Fellowship to Xinyu Yao Tue, 11/09/2021 - 14:19
The Rice computer science doctoral student is one of three award recipients
Kyrillidis urges caution when it comes to quantum computing Thu, 11/04/2021 - 11:29
Rice computer scientist and collaborators have received NSF grants totaling $930,000 to investigate the development of quantum computing.
Kavraki Lab speeds process of identifying potential pandemic treatments Mon, 11/01/2021 - 15:35
Rice web portal helps identify COVID-19 drug candidates